John Paulson Portfolio: Paulson & Co 13F Holdings
Managed by John Paulson
Positions as of Q2 2026 (quarter ended Jun 30, 2026), filed with the SEC on Aug 14, 2026.
John Paulson's fund. Famous for the "Greatest Trade Ever" (subprime short in 2008). Event-driven and merger arb.
13F holdings as of Jun 30, 2026
Source: Paulson & Co Form 13F-HR for Q2 2026, filed Aug 14, 2026, on SEC EDGAR. See our Methodology.
What did Paulson & Co buy and sell in Q2 2026?
Compared with its Q1 2026 filing, Paulson & Co reported 1 new positions, added to 1, reduced 2 and sold out of 2. Changes are measured in shares, so a position can rise in value without being added to.
Top 10 holdings and concentration
Q2 2026The ten largest positions make up 100.0% of the $2.58B reported in long positions, led by MDGL at 27.9%.
Sector allocation
Q2 2026Share of the $2.58B reported, by the sector of each stock. 9.4% is in ETFs, funds and securities without a sector on file.
| Sector | Weight | Positions |
|---|---|---|
| Healthcare | 42.0% | 2 |
| Materials | 32.4% | 2 |
| Financials | 16.2% | 1 |
| Communication Services | 0.1% | 1 |
Paulson & Co 13F holdings, Q2 2026
All 8 positions| # | Company | Shares | Value | Weight | vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | MDGLMADRIGAL PHARMACEUTICALS INC | 1.34M | $719.52M | 27.94% | -4% |
| 2 | PPTAPERPETUA RESOURCES CORP | 32.35M | $671.53M | 26.07% | – |
| 3 | AAMIACADIAN ASSET MANAGEMENT INC | 5.84M | $417.91M | 16.23% | -25% |
| 4 | BHCBAUSCH HEALTH COS INC | 73.26M | $361.15M | 14.02% | – |
| 5 | THMINTERNATIONAL TOWER HILL MIN | 104.49M | $207.93M | 8.07% | +5% |
| 6 | NGNOVAGOLD RESOURCES INC | 27.24M | $162.61M | 6.31% | – |
| 7 | THRYTHRYV HLDGS INC | 8.44M | $33.27M | 1.29% | – |
| 8 | GOOGLALPHABET INC | 5K | $1.77M | 0.07% | NEW |
Paulson & Co portfolio by quarter
4 quarters on fileReported 13F value and position count for each quarter AlphaScala holds for Paulson & Co. Value changes include price moves as well as buying and selling. Position changes are shown only where the quarter was compared with the filing before it.
| Quarter | Reported value | Change | Positions | New | Sold out |
|---|---|---|---|---|---|
| Q2 2026 | $2.58B | -17.2% | 8 | 1 | 2 |
| Q1 2026 | $3.11B | -4.6% | 9 | 1 | 1 |
| Q4 2025 | $3.26B | +9.9% | 9 | 1 | 2 |
| Q3 2025 | $2.97B | – | 10 | – | – |
Funds with overlapping holdings
Overlap is the sum of the smaller portfolio weight for each stock both funds hold, across Paulson & Co's 25 largest positions.
Related data
Data from SEC Form 13F-HR filings, which are due 45 days after quarter end and list long positions in US-listed equities as of that date. Short positions, cash, bonds, non-US holdings and intra-quarter trading are not shown. Listed options are shown separately at notional value. Changes compare the Q2 2026 filing with Q1 2026. Research only – not investment advice.